Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Cash Flow-to-Debt Ratio
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow-to-Debt Ratio of -0.31x as of December 2024, meaning its operating cash flow of CN¥-60.52 Million could theoretically repay 0% of its total liabilities (CN¥192.87 Million) in one year. See financial flexibility index of Shandong Keyuan Pharmaceutical Co. Ltd. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for Shandong Keyuan Pharmaceutical Co. Ltd. A across 4 annual periods. For the full cash flow conversion analysis, see Shandong Keyuan Pharmaceutical Co. Ltd. (301281) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
Year-by-year debt coverage analysis for Shandong Keyuan Pharmaceutical Co. Ltd. A. Check Shandong Keyuan Pharmaceutical Co. Ltd. (301281) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.31x | CN¥-60.52 Million | CN¥192.87 Million | ▼ -217.7% |
| 2023 | 0.27x | CN¥37.03 Million | CN¥138.93 Million | ▼ -69.6% |
| 2022 | 0.88x | CN¥115.86 Million | CN¥132.06 Million | ▲ +116.7% |
| 2021 | 0.40x | CN¥52.02 Million | CN¥128.52 Million | — |